These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 598463)

  • 1. Experimental investigations on increased resistance to infections with Candida albicans and Staphylococcus aureus Smith by 4-imino-1,4-diazobicyclo-(3.1.0)-hexane-2-on BM 06.002 (prop. INN imexon) in mice.
    Ziegler AE; Bicker U; Hebold G
    Exp Pathol (Jena); 1977; 14(6):321-7. PubMed ID: 598463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.
    Nash EE; Peters BM; Fidel PL; Noverr MC
    Infect Immun; 2016 Jan; 84(1):90-8. PubMed ID: 26483410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.
    Peters BM; Noverr MC
    Infect Immun; 2013 Jun; 81(6):2178-89. PubMed ID: 23545303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
    Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
    Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
    [No Abstract]   [Full Text] [Related]  

  • 5. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice.
    Ritz BW
    Nutr Rev; 2008 Sep; 66(9):526-31. PubMed ID: 18752476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopotentiating effect of amphotericin B on resistance to experimental Candida infection in mice.
    Bistoni F; Marconi P; Vecchiarelli A
    Ann Ist Super Sanita; 1987; 23(4):929-33. PubMed ID: 3452290
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma.
    Moehler TM; Feneberg R; Ho AD; Golenkov AK; Ludwig H; Kropff M; Khuageva NK; Hajda J; von Broen I; Goldschmidt H
    Anticancer Drugs; 2010 Aug; 21(7):708-15. PubMed ID: 20571355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunestimulation in cancer patients by a new synthetic compound: BM 06 002.
    Micksche M; Kokoschka EM; Kokron O; Sagaster P; Bicker U
    Osterr Z Onkol; 1977; 4(1):29-32. PubMed ID: 578572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAY 41-2272 activates host defence against local and disseminated Candida albicans infections.
    Soeiro-Pereira PV; Falcai A; Kubo CA; Antunes E; Condino-Neto A
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):75-85. PubMed ID: 25742266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus vulgaris L. and thymol assist murine macrophages (RAW 264.7) in the control of in vitro infections by Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans.
    de Oliveira JR; Figueira LW; Sper FL; Meccatti VM; Camargo SEA; de Oliveira LD
    Immunol Res; 2017 Aug; 65(4):932-943. PubMed ID: 28752199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections.
    Berger M; Kirkpatrick CH; Goldsmith PK; Gallin JI
    J Immunol; 1980 Dec; 125(6):2437-43. PubMed ID: 7000900
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.
    Maródi L; Cypowyj S; Tóth B; Chernyshova L; Puel A; Casanova JL
    J Allergy Clin Immunol; 2012 Nov; 130(5):1019-27. PubMed ID: 23040277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies in animals on the influence of fluocortin butylester on the course of generalized infections (author's transl)].
    Kessler HJ; Haude D; Okon C; Schumann P
    Arzneimittelforschung; 1977; 27(11a):2214-6. PubMed ID: 341900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
    Kong EF; Kucharíková S; Van Dijck P; Peters BM; Shirtliff ME; Jabra-Rizk MA
    Infect Immun; 2015 Feb; 83(2):604-13. PubMed ID: 25422264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(1)]-propane BM 12 531.
    Bicker U; Hebold G; Ziegler AE; Maus W
    Exp Pathol (Jena); 1978; 15(1):49-62. PubMed ID: 346364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice.
    Kullberg BJ; van 't Wout JW; Hoogstraten C; van Furth R
    J Infect Dis; 1993 Aug; 168(2):436-43. PubMed ID: 8335982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Inverse" effects of cortisone in experimental infection of mice.
    Gillissen G
    Adv Exp Med Biol; 1992; 319():137-43. PubMed ID: 1414589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunestimulation by 4-imino-1,3-diazabicyclo(3.1.0.)-hexan-2-on (BM 06.002).
    Cerni CM; Rella WA; Bicker U
    Osterr Z Onkol; 1977; 4(1):20-2. PubMed ID: 333345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EXPERIMENTAL MIXED INFECTIONS IN MICE. STAPHYLOCOCCUS AUREUS AND CANDIDA ALBICANS.
    LEPPER MH; CHOMET B; KARKLYS E
    Arch Environ Health; 1964 Apr; 8():570-83. PubMed ID: 14107668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.